Medical News Today report that SGX393 is effective against Gleevec-resistant chronic myeloid leukemia (CML).

New Research Gives Additional Therapeutic Tools For Even More Effective And Longer Control Of Chronic Myeloid Leukemia Main Category: Lymphoma / Leukemia Article Date: 25 Mar 2008 Oregon Health & Science University Cancer Institute researchers have found that an experimental drug known as SGX393 is effective against Gleevec-resistant chronic myeloid leukemia (CML). The results of their study will be published the week of March 24th in the Proceedings of the National Academy of Sciences.